rβ2-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity

Abstract

In dopaminergic (DA) substantia nigra (SN) neurons Cav2.3 R-type Ca2+-currents contribute to somatodendritic Ca2+-oscillations. This activity may contribute to the selective degeneration of these neurons in Parkinson's disease (PD) since Cav2.3-knockout is neuroprotective in a PD mouse model. Here we show that in tsA-201-cells the membrane-anchored β2-splice variants β2a and β2e are required to stabilize Cav2.3 gating properties allowing sustained Cav2.3 availability during simulated pacemaking and enhanced Ca2+-currents during bursts. We confirmed the expression of β2a- and β2e-subunit transcripts in the mouse SN and in identified SN DA neurons. Patch-clamp recordings of mouse DA midbrain neurons in culture and SN DA neurons in brain slices revealed SNX-482-sensitive R-type Ca2+-currents with voltage-dependent gating properties that suggest modulation by β2a- and/or β2e-subunits. Thus, β-subunit alternative splicing may prevent a fraction of Cav2.3 channels from inactivation in continuously active, highly vulnerable SN DA neurons, thereby also supporting Ca2+ signals contributing to the (patho)physiological role of Cav2.3 channels in PD.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Raw data have been provided for mean population data shown in Figures and Tables.

The following previously published data sets were used

Article and author information

Author details

  1. Anita Siller

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  2. Nadja T Hofer

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Giulia Tomagra

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Nicole Wiederspohn

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Simon Hess

    Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Julia Benkert

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Aisylu Gaifullina

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Desiree Spaich

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Johanna Duda

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Christina Poetschke

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Kristina Vilusic

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  12. Eva Maria Fritz

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  13. Toni Schneider

    Institute of Neurophysiology, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Peter Kloppenburg

    Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4554-404X
  15. Birgit Liss

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Valentina Carabelli

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
  17. Emilio Carbone

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2239-6280
  18. Nadine Jasmin Ortner

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    For correspondence
    nadine.ortner@uibk.ac.at
    Competing interests
    The authors declare that no competing interests exist.
  19. Jörg Striessnig

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    For correspondence
    joerg.striessnig@uibk.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9406-7120

Funding

Austrian Science Fund (P27809,P35722,CavX-DOC 30 doc.fund)

  • Jörg Striessnig

Tyrolean Science Fund (UNI-0404/2345)

  • Nadine Jasmin Ortner

Italian Miur (2015FNWP34)

  • Emilio Carbone

Compagnia di San Paolo (CSTO165284)

  • Emilio Carbone

Austrian Science Fund (P35087)

  • Nadine Jasmin Ortner

Hamburg Institute for Advanced Study (Research Fellowship)

  • Birgit Liss

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Henry M Colecraft, Columbia University, United States

Ethics

Animal experimentation: All animal experiments and procedures were performed in strict accordance with the European Community's Council Directive 2010/63/UE and approved by the Italian Ministry of Health and the Local Organism responsible for animal welfare at the University of Torino (authorization DGSAF 0011710-P-26/07/2017) and the local authorities at the University of Ulm (Regierungspräsidium Tübingen, Ref: 35/9185.81-3; Reg. Nr. o.147) and University of Cologne (LANUV NRW, Recklinghausen, Germany (84-02.05.20.12.254).

Version history

  1. Preprint posted: February 10, 2021 (view preprint)
  2. Received: February 11, 2021
  3. Accepted: July 4, 2022
  4. Accepted Manuscript published: July 6, 2022 (version 1)
  5. Accepted Manuscript updated: July 8, 2022 (version 2)
  6. Version of Record published: July 22, 2022 (version 3)
  7. Version of Record updated: July 27, 2022 (version 4)

Copyright

© 2022, Siller et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,136
    views
  • 326
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anita Siller
  2. Nadja T Hofer
  3. Giulia Tomagra
  4. Nicole Wiederspohn
  5. Simon Hess
  6. Julia Benkert
  7. Aisylu Gaifullina
  8. Desiree Spaich
  9. Johanna Duda
  10. Christina Poetschke
  11. Kristina Vilusic
  12. Eva Maria Fritz
  13. Toni Schneider
  14. Peter Kloppenburg
  15. Birgit Liss
  16. Valentina Carabelli
  17. Emilio Carbone
  18. Nadine Jasmin Ortner
  19. Jörg Striessnig
(2022)
rβ2-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity
eLife 11:e67464.
https://doi.org/10.7554/eLife.67464

Share this article

https://doi.org/10.7554/eLife.67464

Further reading

    1. Immunology and Inflammation
    2. Neuroscience
    Irini Papazian, Maria Kourouvani ... Lesley Probert
    Research Article

    Autoimmune diseases of the central nervous system (CNS) such as multiple sclerosis (MS) are only partially represented in current experimental models and the development of humanized immune mice is crucial for better understanding of immunopathogenesis and testing of therapeutics. We describe a humanized mouse model with several key features of MS. Severely immunodeficient B2m-NOG mice were transplanted with peripheral blood mononuclear cells (PBMCs) from HLA-DRB1-typed MS and healthy (HI) donors and showed rapid engraftment by human T and B lymphocytes. Mice receiving cells from MS patients with recent/ongoing Epstein–Barr virus reactivation showed high B cell engraftment capacity. Both HLA-DRB1*15 (DR15) MS and DR15 HI mice, not HLA-DRB1*13 MS mice, developed human T cell infiltration of CNS borders and parenchyma. DR15 MS mice uniquely developed inflammatory lesions in brain and spinal cord gray matter, with spontaneous, hCD8 T cell lesions, and mixed hCD8/hCD4 T cell lesions in EAE immunized mice, with variation in localization and severity between different patient donors. Main limitations of this model for further development are poor monocyte engraftment and lack of demyelination, lymph node organization, and IgG responses. These results show that PBMC humanized mice represent promising research tools for investigating MS immunopathology in a patient-specific approach.

    1. Neuroscience
    Ju-Young Lee, Dahee Jung, Sebastien Royer
    Research Article

    Animals can use a repertoire of strategies to navigate in an environment, and it remains an intriguing question how these strategies are selected based on the nature and familiarity of environments. To investigate this question, we developed a fully automated variant of the Barnes maze, characterized by 24 vestibules distributed along the periphery of a circular arena, and monitored the trajectories of mice over 15 days as they learned to navigate towards a goal vestibule from a random start vestibule. We show that the patterns of vestibule visits can be reproduced by the combination of three stochastic processes reminiscent of random, serial, and spatial strategies. The processes randomly selected vestibules based on either uniform (random) or biased (serial and spatial) probability distributions. They closely matched experimental data across a range of statistical distributions characterizing the length, distribution, step size, direction, and stereotypy of vestibule sequences, revealing a shift from random to spatial and serial strategies over time, with a strategy switch occurring approximately every six vestibule visits. Our study provides a novel apparatus and analysis toolset for tracking the repertoire of navigation strategies and demonstrates that a set of stochastic processes can largely account for exploration patterns in the Barnes maze.